3I6L
Newly identified epitope N1 derived from SARS-CoV N protein complexed with HLA-A*2402
Summary for 3I6L
Entry DOI | 10.2210/pdb3i6l/pdb |
Descriptor | HLA class I histocompatibility antigen, A-24 alpha chain, Beta-2-microglobulin, Nucleoprotein peptide, ... (4 entities in total) |
Functional Keywords | hla-a*2402, sars-cov, nucleocapsid protein, disulfide bond, glycoprotein, host-virus interaction, immune response, membrane, mhc i, transmembrane, disease mutation, glycation, immunoglobulin domain, pyrrolidone carboxylic acid, secreted, golgi apparatus, phosphoprotein, ribonucleoprotein, rna-binding, viral nucleoprotein, virion, immune system |
Biological source | Homo sapiens (human) More |
Cellular location | Membrane; Single-pass type I membrane protein: P05534 Secreted: P61769 Virion: P59595 |
Total number of polymer chains | 3 |
Total formula weight | 44521.54 |
Authors | Liu, J.W. (deposition date: 2009-07-07, release date: 2010-07-14, Last modification date: 2023-11-01) |
Primary citation | Liu, J.,Wu, P.,Gao, F.,Qi, J.,Kawana-Tachikawa, A.,Xie, J.,Vavricka, C.J.,Iwamoto, A.,Li, T.,Gao, G.F. Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein J.Virol., 84:11849-11857, 2010 Cited by PubMed: 20844028DOI: 10.1128/JVI.01464-10 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.4 Å) |
Structure validation
Download full validation report